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IMPORTANCE A new analysis method called permutation of pointwise linear regression
measures the significance of deterioration over time at each visual field location, combines
the significance values into an overall statistic, and then determines the likelihood of change
in the visual field. Because the outcome is a single P value, individualized to that specific
visual field and independent of the scale of the original measurement, the method is well
suited for comparing techniques with different stimuli and scales.
OBJECTIVE To test the hypothesis that frequency-doubling matrix perimetry (FDT2) is more
sensitive than standard automated perimetry (SAP) in identifying visual field progression in
glaucoma.
DESIGN, SETTING, AND PARTICIPANTS Patients with open-angle glaucoma and healthy
controls were examined by FDT2 and SAP, both with the 24-2 test pattern, on the same day at
6-month intervals in a longitudinal prospective study conducted in a hospital-based setting.
Only participants with at least 5 examinations were included.
INTERVENTION Data were analyzed with permutation of pointwise linear regression.
MAIN OUTCOME ANDMEASURE Permutation of pointwise linear regression is individualized to
each participant, in contrast to current analyses in which the statistical significance is inferred
from population-based approaches. Analyses were performedwith both total deviation and
pattern deviation.
RESULTS Sixty-four patients and 36 controls were included in the study. Themedian age, SAP
mean deviation, and follow-up period were 65 years, −2.6 dB, and 5.4 years, respectively, in
patients and 62 years, +0.4 dB, and 5.2 years, respectively, in controls. Using total deviation
analyses, statistically significant deterioration was identified in 17% of patients with FDT2, in
34% of patients with SAP, and in 14% of patients with both techniques; in controls these
percentages were 8%with FDT2, 31%with SAP, and 8%with both. Using pattern deviation
analyses, statistically significant deterioration was identified in 16% of patients with FDT2, in
17% of patients with SAP, and in 3% of patients with both techniques; in controls these values
were 3%with FDT2 and none with SAP.
CONCLUSIONS AND RELEVANCE No evidence was found that FDT2 is more sensitive than SAP
in identifying visual field deterioration. In about one-third of healthy controls, age-related
deterioration with SAP reached statistical significance.
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S tandard automated perimetry (SAP) is performed clini-cally tomonitor visual field deterioration in glaucoma.Despite its wide use, the value of the techniquemay be
limited by the greater variability of thresholds with increas-
ingvisual fielddamage.1-4 Furthermore, a considerable length
of time (often years) of frequent examinations may be re-
quired to confidently identify deterioration.5-8
Frequency-doubling perimetry (FDT1) and its successor,
frequency-doublingmatrixperimetry (FDT2),weredevised to
offer earlier detection of glaucomatous visual field loss than
SAP.9,10Thestimuluswas thought toselectivelystimulatemag-
nocellular retinal ganglion cells (RGCs)10 thatwere believed to
be lostpreferentially inearlyglaucoma.11UnlikeSAP,12 the test-
retestvariabilitywithFDT12andFDT24,13doesnot increasewith
decreasingsensitivity. In2009,ourgroupreportedahigher sig-
nal-noise ratio for FDT2 compared with SAP in cross-
sectional data and hypothesized that FDT2 might also be su-
perior to SAP in detecting glaucomatous visual field
deterioration over time.14
Several studies13,15-17haveshownthatFDT2performssimi-
larly to SAP in identifying visual fielddamage in glaucoma, al-
thoughother investigatorshavenot concurred.18However, the
performanceof the technique in identifyingdeteriorationover
time isunknown.Todate, published longitudinal data are lim-
ited to FDT1, which uses a coarser test pattern and a different
thresholdingalgorithmcomparedwithFDT2.Witheventanaly-
sis, Bayer and Erb19 reported that FDT1 identified deteriora-
tion over time inmorepatients than SAP. Similarly,with glau-
coma change probability analysis, Haymes and colleagues20
reported that deterioration was identified in more patients
usingFDT1 comparedwith SAP; however, linear regression of
global and sectoral data suggested the opposite.
In this study,wecomparedtheproportionsofpatientswith
glaucoma and healthy controls, followed up prospectively by
FDT2 and SAP, who had statistically significant overall visual
field deterioration. The statistical significance is derivedwith
a new analysis method called permutation of pointwise lin-
ear regression (PoPLR).21 This method measures the signifi-
cance of deterioration over time at each visual field location,
combining significancevalues intoa singleoverall statistic and
determining the likelihoodof that statistic existingbecauseof
chancealone.Because theoutcomeofPoPLR is a singlePvalue
independentof the scaleoforiginalmeasurement, themethod
is well suited for comparison of techniques with different
stimuli and measurement scales.
Methods
Participants
The study adhered to the tenets of theDeclaration ofHelsinki.
Ethics approval was obtained from the Capital Health Re-
search Ethics Board, and all participants provided written in-
formed consent before examinations. The participants in this
studyweredrawnfromanongoingprospective longitudinal in-
vestigation on functional and structural changes in open-
angle glaucoma and in normal aging,14,22 to which FDT2 test-
ingwassubsequentlyadded.Commoninclusioncriteria for the
longitudinal investigation (before the additionofFDT2)were a
best-correctedvisual acuity of +0.3 logarithmof theminimum
angleofresolution(20/40)orbetter,arefractiveerrorwithin5-di-
opter (D) equivalent sphere and3-Dastigmatism, andat least 5
pairs of FDT2 and SAP examinations, with each pair con-
ducted on the same day. Patients were included if they had a
clinical diagnosis of open-angle glaucoma, a SAPmean devia-
tion (MD) between −2 and −10 dB, optic disc damage consis-
tent with the clinical diagnosis, and no other ocular disease. If
both eyes were eligible, one eye was randomly selected as the
study eye. Controls had normal eye examination findings and
an intraocular pressure of less than 21mmHg. All participants
were experiencedwith both tests at baseline. Patientswere re-
cruited from the clinics of the Queen Elizabeth II Health Sci-
ences Centre, and controls were recruited from church groups
or a local telephone company or were patients’ relatives.
Perimetric Tests
All participants were followed upwith FDT2 (HumphreyMa-
trix;CarlZeissMeditec)andSAP(HumphreyFieldAnalyzer750;
Carl Zeiss Meditec) in examinations on the same day every 6
months. Patientshadonepair of additional examinationswith
each technique in the initial follow-up part of the study that
was also included in the analyses.
The FDT2 technique uses sinusoidal grating stimuli (0.50
cycles per degree), eachwithin a squarewindow (5° × 5°) un-
dergoing 18-Hz counterphase flicker. The zippy estimation of
sequential thresholds algorithm is used to measure
sensitivity.23 This algorithm is based onmaximum likelihood
estimation, in which a probability density function is multi-
plied by yes or no likelihood functions, depending on the re-
sponse, togenerate anewprobabilitydensity function thatde-
termines thenext stimulus intensity tobepresented.Normally,
the test terminates after 4 presentations at each location. The
SAP technique was performed with the Swedish interactive
thresholding algorithm standard thresholding strategy24 and
aGoldmann III stimulus (0.43° diameter).While the zippy es-
timationofsequential thresholdsprocedureofFDT2yieldssen-
sitivity values ranging from 0 to 38 dB, there are only 15 dis-
crete, irregularly distributed levels. The Swedish interactive
thresholdingalgorithmstandard strategyofSAPyieldsover40
more uniformly distributed levels. The 24-2 test pattern was
used with both techniques, each testing the same number of
locations. Theanalyseswereperformedwithdata from52 test
locations fromeach FDT2 and SAP visual field after exclusion
of the foveal and 2 blind spot locations.
Statistical Analysis
The statistical significanceof differences between characteris-
tics of patients and controls was assessed using the Mann-
Whitney test. The statistical significance of visual field dete-
riorationwasdeterminedforeachparticipantusingPoPLR.This
technique, along with a formal validation, is described in de-
tail elsewhere.21 Briefly, the objective of PoPLR is to derive a
single statistic to determine whether statistically significant
pointwisedeteriorationhasoccurred inthevisual field.Foreach
participant, pointwise ordinary least squares linear regression
was performed, resulting in a P value for deterioration at each
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location. Thereafter, the P < .05 values were combined25,26 to
provide a single observed statistic (Sobs). The sequence of vi-
sual field testswas thenrandomlyreordered(orpermuted),and
a single statistic was derived for each permuted test sequence
(Sp). The number of permutated sequences available depends
on the number of actual examinations. For participants with 5
and6examinations, thereare120(5 × 4 × 3 × 2 × 1)and720pos-
siblepermutedsequences, respectively, allowingempiricalnull
distributions of Sp to be computedwith adequate precision. In
participants with 7 examinations, there are 5040 possible se-
quences. For practical computation time, 5000 randomly se-
lected sequences from the total available were used in partici-
pants with 7 or more examinations, while all permuted
sequences were used for participants with 5 or 6 examina-
tions.Thereafter, eachparticipant’sSobswascomparedwith the
distributionofSpderivedonly fromhisorherowndata.Thesta-
tistical significance (overallP value) of Sobswas determined by
its position in the distribution of Sp. To permit high specificity,
statistically significantvisual fielddeteriorationwasdefinedas
overall P < .01. The analyseswere performed for both total de-
viation (TD) and pattern deviation (PD) data.
Thenumber of patients and controlswith statistically sig-
nificant deteriorationover timewas comparedbetweenFDT2
and SAP. The statistical significance of differences in the
proportion of participants identified as having deterioration
with FDT2 and SAP was assessed with the McNemar test of
pairedproportions.Fordescriptivepurposes,Cohenκwasused
to assess the agreement between techniques in identifying
deterioration.
To investigate the relationship between deterioration and
baselinevisual fieldsensitivity, theproportionofvisual field lo-
cationswithstatistically significantdeteriorationover time,de-
termined by pointwise linear regression (P < .05), was as-
sessed across 4 strata defined by baseline sensitivity. Initially,
a frequencydistributionof all baseline sensitivityvalues for all
participants (5200 values in total) was derived. To account for
theunequally spacedFDT2threshold levels, test locationswere
grouped according to the 26th, 54th, and 87th percentiles of
baseline sensitivity to obtain approximately equal-sized strata
representing low, mid, high, and very high baseline sensitiv-
ity. Within each stratum, the number and proportion of loca-
tionswith statistically significantdeteriorationover timewere
calculated. The same percentile cutoffs were applied to SAP.
Results
Sixty-fourpatients and36 controls qualified for the study. The
demographic data, aswell as the baseline and follow-up sum-
mary visual field data, are given in Table 1. The rates of MD
changewithFDT2andSAPand their SEs are shown inFigure 1.
Patients had a steeper negative MD rate using both FDT2 and
SAP compared with controls (Table 2).
ParticipantsWith Statistically Significant Deterioration
The agreement between FDT2 and SAP in identifying visual
fielddeterioration is shownforpatients inFigure2and for con-
Table 1. Demographic and Visual Field Data
Variable
Median (Interquartile Range) [Range]
Patients Controls
Baseline age, y 65 (58 to 71)
[40 to 90]
62 (55 to 70)
[47 to 86]
Follow-up period, y 5.4 (4.8 to 5.6)
[1.9 to 6.0]
5.2 (4.0 to 5.6)
[2.2 to 6.0]
No. of examinations 12 (10 to 12)
[6 to 14]
10 (8 to 11)
[5 to 13]
Baseline refractive
error, Da
−0.8 (−3.0 to +0.1)
[−6.8 to +5.0]
0.0 (−0.7 to +0.1)
[−3.5 to +5.5]
Baseline MD, dB
FDT2 −6.5 (−9.5 to −1.8)
[−21.4 to +2.6]
−0.2 (−1.7 to +1.6)
[−3.9 to +4.3]
SAP −2.6 (−6.0 to −0.9)
[−25.9 to +1.6]
+0.4 (−0.7 to 1.1)
[−7.4 to +4.4]
Final MD, dB
FDT2 −7.3 (−10.6 to −2.9)
[−19.2 to +1.3]
−0.3 (−1.8 to 1.9)
[−6.0 to +4.8]
SAP −4.0 (−7.1 to −1.3)
[−19.2 to +1.3]
+0.1 (−0.7 to 1.1)
[−4.4 to +1.9]
Abbreviations: FDT2, frequency-doubling matrix perimetry; MD, mean
deviation; SAP, standard automated perimetry.
a Spherical equivalent.
Figure 1. Individual Mean Deviation (MD) RatesWith Frequency-DoublingMatrix Perimetry (FDT2) and
Standard Automated Perimetry (SAP) and Their SEs
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trols inFigure3.WithTD,FDT2 identifieddeterioration in fewer
patients and controls than SAP (P = .01 for both). All controls
identified by FDT2 as having deterioration with TDwere also
identified by SAP with TD. The proportions of patients hav-
ing deterioration with PD were similar between both tech-
niques (P > .99) (Figure 2); however, only 2 patients showed
deterioration with both. Deterioration with TD was identi-
fied in 1 control with FDT2 and in none with SAP. Agreement
between FDT2 and SAP was moderate with TD for both pa-
tients (κ = 0.44) and controls (κ = 0.34) but was low with PD
for both patients (κ = 0.03) and controls (κ = 0.00). The bot-
tom panels in Figures 2 and 3 show the distribution of overall
P values analyzed by PoPLR for FDT2 and SAP (TD and PD).
Baseline Sensitivity and Deterioration Over Time
Thedistribution of pointwise baseline sensitivity values in all
participants for both FDT2 and SAP (5200 for each) is shown
inFigure4. Becauseofonly 15possiblediscrete sensitivityval-
ues with FDT2, the corresponding 4 strata for FDT2 and SAP
contain approximately (but not exactly) the same number of
locations. Significantdeterioration (P < .05)occurredat all lev-
els of damage for FDT2 and for SAP.Withboth techniques, the
mid-sensitivity and high-sensitivity strata spanned a narrow
sensitivity range. Between corresponding strata, the number
of locations with deterioration over time was always higher
with SAP than with FDT2.
Case Examples
Three case examples are shown in eFigure 1 in the Supple-
ment,eFigure2 in theSupplement,andeFigure3 in theSupple-
ment (patients A, B, and C, respectively). For patient A (eFig-
ure 1 in the Supplement), FDT2 and SAP showpredominantly
inferior visual field damage. Further deterioration ismore ap-
Table 2. Rate ofMean Deviation (MD) Change Statistics
Variable
Median (Interquartile Range) [Range]
Patients Controls
FDT2
MD change rate, dB/y −0.19 (−0.44 to 0.00)
[−2.33 to +1.11]
−0.05 (−0.19 to 0.14)
[−1.42 to +0.78]
SE of MD rate, dB 0.24 (0.16 to 0.32)
[0.10 to 1.30]
0.18 (0.15 to 0.27)
[0.09 to 0.82]
SD of residuals, dB 1.25 (0.96 to 1.54)
[0.55 to 2.99]
0.88 (0.83 to 1.05)
[0.52 to 1.47]
SAP
MD change rate, dB/y −0.16 (−0.40 to +0.01)
[−2.02 to +2.84]
−0.06 (−0.16 to 0.9)
[−0.91 to +0.49]
SE of MD rate, dB 0.14 (0.10 to +0.19)
[0.04 to 1.03]
0.13 (0.09 to 0.20)
[0.04 to 0.39]
SD of residuals, dB 0.71 (0.51 to 0.98)
[0.21 to 5.04]
0.58 (0.39 to 0.67)
[0.19 to 2.2]
Abbreviations: FDT2, frequency-doubling matrix perimetry; SAP, standard
automated perimetry.
Figure 2. Agreement Between Frequency-DoublingMatrix Perimetry (FDT2) and Standard Automated
Perimetry (SAP) in Identifying Overall Deterioration in PatientsWith Glaucoma at the 1% Significance Level
(P<.01) for Total Deviation and Pattern Deviation Analyses
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parent in the inferior field and is statistically significant with
SAP but only borderline significant with FDT2. For patient B
(eFigure 2 in the Supplement), FDT2 and SAP showmoderate
visual field loss,with rapid deterioration in the superior field.
Deterioration is statistically significant with both tech-
niques. For patient C (eFigure 3 in the Supplement), FDT2 and
SAPshowdense superior visual fielddamage,with furtherde-
terioration at only 2 locations with FDT2 and 1 location with
SAP. Overall, PoPLR indicated that this deterioration was not
statistically significant.
For eachpatient, only theTDanalyses are shown.TheMD
rates and their SEs for patients A, B, and C are also shown in
Figure 1.
Discussion
This studyexaminedvisual fielddeterioration inglaucomapa-
tientsandhealthycontrolswithFDT2andSAPusinganewana-
lytical technique called PoPLR. Progression was identified in
fewer glaucomapatientswithFDT2 comparedwith SAPusing
bothTDandPDanalyses. Controlswere also identified ashav-
ingdeteriorationwithboth techniquesbutparticularly bySAP
withTDanalysis. Agreement between techniques in the iden-
tification of deteriorationwasmoderatewithTDanalysis and
poor with PD analysis.
Frequency-doubling perimetry was developed in an at-
tempt toestablishamore sensitive test of earlyvisual field loss
due toglaucoma.9 Itwas thought that the large sinusoidal grat-
ing stimulus, with its low spatial and high temporal fre-
quency, selectively stimulated magnocellular RGCs.10 This
small subset ofRGCswith their larger-diameter axons arepur-
portedlydamagedearlier in glaucoma11,27; however, this find-
inghasnotbeenuniversally confirmed.28-30Furthermore,with
direct recordings fromprimate retinas, itwas reported in 2011
that the SAP stimulus, conventionally thought to be nonse-
lective to the different subsets of RGCs, showed greater pref-
erential stimulation of magnocellular RGCs over parvocellu-
lar RGCs than the frequency-doubling stimulus.31
Direct comparisons between FDT2 and SAP in measur-
ing glaucomatous visual field damage and its progression
are problematic for several reasons. Among these are differ-
ences in the stimulus area, imperfect matching of stimulus
locations, and variations between thresholding algorithms
(which in turn lead to variations in the number and arrange-
ment of possible sensitivity levels analyzed by the tech-
niques), as well as different measurement scales. Although
both techniques analyze sensitivity in decibel scales that
have a similar numerical range, it cannot be assumed, for
example, that deterioration of 1.0 dB/y with FDT2 is equiva-
lent to deterioration of 1.0 dB/y with SAP. Therefore, we
compared FDT2 and SAP solely on the basis of the statistical
Figure 3. Agreement Between Frequency-DoublingMatrix Perimetry (FDT2) and Standard Automated
Perimetry (SAP) in Identifying Overall Deterioration in Healthy Controls at the 1% Significance Level (P<.01) for
Total Deviation and Pattern Deviation Analyses
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significance of deterioration derived from PoPLR rather
than on the magnitude (in decibels) or the rate of deteriora-
tion (in decibels per year). While it is difficult to estimate
the statistical power of PoPLR in the absence of a commonly
agreed on model of visual field deterioration, our group has
previously demonstrated that PoPLR provides at least equal
and often superior performance in detecting evidence of
change compared with other techniques.21
Current progression analyses with change probability
maps32 are based on the test-retest variability estimates ob-
tained from large samples andnot from the individual partici-
pantwhosevisual field is beingevaluated.The test-retest vari-
ability at a given location is pooled across participants and is
assumed to represent the true variability in an individual par-
ticipant.Hence, the assumption that themagnitudeof change
required for statistical significance is the same for all partici-
pants is likely invalid and leads to a large range of false-
positive events when patients are examined over time.33 An
advantage of PoPLR is that, by using individual cutoffs rather
than population-based cutoffs for the statistical significance,
amore accurate assessmentof an individual’s visual fieldover
timecanbemade.Furthermore, because anoverallPvalue in-
dependent of criteria and themagnitude of change defining a
deterioratingvisual field isused, ameaningful comparisonbe-
tween techniques operating on different scales, such as FDT2
and SAP, can be made.
Using TD analyses, SAP identified visual field deteriora-
tion in 22 patients (34%), twice as many as showing deterio-
rationwithFDT2 (11patients [17%]).While lowspecificity (high
false-positive rate) would result in a falsely high frequency of
patients identified as having deterioration with SAP, this ex-
planation is highlyunlikely because, as previously reported,21
Figure 4. Distribution of Baseline Sensitivity Values for All Visual Field Locations in All Participants Using
Frequency-DoublingMatrix Perimetry (FDT2) and Standard Automated Perimetry (SAP)
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the observed false-positive rate with PoPLR closely matches
the nominal significance level. Hence, at the 1% significance
level, for example, approximately 1%of participants showde-
terioration in the permuted visual field series. Therefore, our
results indicate that, with TD analyses, SAPwas twice as sen-
sitive as FDT2 in detecting visual field deterioration in pa-
tients having glaucoma. Using PD analyses, approximately
equalnumbersofpatientshavingglaucomawithFDT2andSAP
were identified as having visual field deterioration. This find-
ing suggests that the origin of the changes observedwith SAP
were more diffuse or widespread.
Using TD analyses, SAP identified visual field deteriora-
tion in 11 controls (31%), a frequency similar to that in pa-
tients. These changes are likely genuine; however, the mag-
nitudeof changewas smaller than that inpatients (averageMD
change of −0.06dB/y in controls comparedwith −0.16 dB/y in
patients).Totaldeviation iscalculatedfromthedecrease insen-
sitivity,withagedeterminedfromcross-sectionaldata ina large
population sample rather than from individuals followed up
over time. In reality, the decline in sensitivity with aging oc-
curs at different rates in different individuals; therefore, TD
doesnot accurately capture theseeffects in individuals. Taken
together, our findings indicate that SAP can detect age-
related changes in healthy individuals when statistical tech-
niques that account for the nature of an individual partici-
pant’sdataareconsidered.UsingPoPLR,FDT2detectedchange
in 3 controls (8%), a figure lower than that observedwith SAP.
Using PD analyses, the proportion of controls having statisti-
cally significantdeteriorationwitheither techniquewasmuch
lower, indicating that PoPLRwithPDvalues ismore appropri-
ate than that with TD values in the detection of focal glauco-
matous visual field deterioration.
Themid-range tohigh-rangebaseline sensitivity strata for
both FDT2 and SAP (containing more than one-half of the lo-
cations in patients and controls) represented a narrow range
of discrete sensitivity values (3 levels [19, 22, and 26 dB] for
FDT2 and 6 levels [26-31 dB] for SAP) compared with the en-
tire dynamic range of the instruments. At this range of sensi-
tivity, the test-retest variability of SAP is the lowest,13 provid-
ing the best performance characteristics. This narrow range
likely drives the performance of FDT2 and SAP in identifying
deterioration over time, at least in patients with early glau-
coma. These findings are contrary to those by Boden and
colleagues,34 who reported that most deterioration occurred
in more damaged regions of the visual field.
In conclusion, our findings do not support the hypoth-
esis that FDT2 is more sensitive than SAP in identifying
visual field deterioration. In about one-third of healthy con-
trols, age-related deterioration with SAP reached statistical
significance.
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